Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 506 - Robust and Efficient Analysis of Complex Time-to-Event Data
Type: Topic Contributed
Date/Time: Thursday, August 11, 2022 : 8:30 AM to 10:20 AM
Sponsor: ENAR
Abstract #323336
Title: Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event
Author(s): Mouna Akacha *
Companies: Novartis Pharma AG
Keywords: estimands; recurrent events ; causal inference; competing risk
Abstract:

Treatment effects on recurrent events are of primary clinical interest in many diseases such as asthma or chronic heart failure. When death makes it impossible to experience further events, defining an appropriate measure of the treatment effect, the estimand, is challenging. For example in chronic heart failure, patients may experience repeated hospitalizations, but are also at an increased risk of death. For a test treatment which reduces mortality compared to a control treatment, one may observe more hospitalizations under the test treatment simply because patients with a high risk of hospitalizations may die earlier under the control treatment. Many statistical analysis procedures have been proposed for such data, however it is often unclear which estimands these imply. As emphasized in the causal inference literature and the ICH E9(R1) guideline, the definition of the estimand of interest should precede any statistical analysis. We focus here on estimands for recurrent events terminated by death that have a causal interpretation. We also discuss whether common statistical analyses imply causal estimands of interest. Chronic heart failure is used as a motivating example.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program